In recent years, CFOs have assumed increasingly complex, strategic roles focused on driving value creation across the business. Growing shareholder expectations and
activism, more intense M&A, mounting regulatory scrutiny over corporate conduct and evolving expectations from the finance function have put CFOs in the middle of corporate decisions.
While financial performance is what it is, the CFO’s role in helping stakeholders interpret the numbers in the context of the business environment is critical. This article explains the significance of the role that CFOs have to play in managing investors, communicating with customers, suppliers and internal teams, Continue reading →
S. Venkat and Abhiram Kandoor explain why education businesses need good CFOs
While the education sector has seen explosive growth in recent times, investments by PE funds and emergence of organised corporates, the sector is also faced with challenges due to government intervention, rules and regulations covering partnerships, capacity building and even pricing and requirements of large upfront capital investments. Whether it is pre-primary, K12, higher education skills or online assessment businesses, navigating choppy business waters without a good CFO at the helm can be daunting for management.
Cash flows can be the one of the strongest indicators of an e-commerce business’s success or failure.
Cash flow in simple terms is the difference in time between when you get paid and when you pay. The sector has been in the news and is seen as one of the fastest growing amongst new age industry sectors in the next decade. With significant foreign investments in the sector in the last three years alone, Continue reading →
Our client Pharmax is a family owned and managed company with turnover close to INR 700 Crores. Pharmax is a leading name in the Active Pharmaceutical Ingredient (API) and Finished Drug Formulation (FDF) segments which is sold in both the regulated and the generic markets in India and over 50 countries worldwide. The company has state of the art manufacturing facilities approved by US FDA and has 17 Abbreviated New Drug Application (ANDA) filed and 12 in the pipeline.
Challenges for MyCFO:
Budgeting at Pharmax was a simple ‘spread sheeting’ exercise restricted only to collation of data inputs received from various departments. The variance between budgets and actuals for instance in financial year 13-14 was more than 80%. The variances were reported every month to the HOD’s and the management on a month on month basis for their review and comments. Continue reading →